Endothelial and smooth muscle cells express leukocyte adhesion molecules heterogeneously during acute rejection of rabbit cardiac allografts.

Interactions of leukocytes with vascular wall cells figure prominently in acute rejection and development of vascular occlusive disease after cardiac transplantation. To investigate the time course and distribution among different types of vessels of expression of endothelial leukocyte adhesion molecules, issues difficult to address in humans, we studied heterotopic transplants of Dutch-Belted rabbit hearts into New Zealand white recipients without immunosuppression (average time to graft failure 8.2 +/- 0.4 days). We found constitutive expression of vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) by coronary arterial endothelium in normal rabbits, whereas myocardial capillaries and the endocardial lining cells showed little or no expression of VCAM-1. VCAM-1 expression increased within 1 day after transplantation on the endothelium of the transplanted aorta and endocardium and on myocardial microvascular endothelial cells. ICAM-1 expression increased remarkably on all endothelia studied from 2 to 8 days after transplantation. Adhesion molecule expression on coronary artery endothelial cells also increased during severe allograft rejection (from a histological score of 1.7 +/- 0.6 pretransplant to 4.8 +/- 0.2 8 days after transplant for VCAM-1 and from 0.9 +/- 0.6 to 4.4 +/- 0.3 for ICAM-1, n = 43 arteries in 5 animals, mean +/- SD). In addition, coronary artery and aortic smooth muscle cells also showed induction of VCAM-1 and ICAM-1 8 days after transplant. We conclude that endothelial activation in a transplanted organ can occur rapidly and varies among microvascular, endocardial, and coronary artery endothelial cells, a point germane to the interpretation of endomyocardial biopsies. Augmented expression of adhesion molecules precedes temporally leukocyte accumulation in vessels. In addition, our finding of activation of coronary artery smooth muscle cells during acute rejection suggests that such episodes may contribute to the development of accelerated coronary arteriosclerosis.

[1]  P. Libby,et al.  Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. , 1993, The American journal of pathology.

[2]  P. Libby,et al.  Vascular cell adhesion molecule-1 and smooth muscle cell activation during atherogenesis. , 1993, The Journal of clinical investigation.

[3]  M. Ferguson,et al.  Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. , 1993, The Journal of clinical investigation.

[4]  T. McDonald,et al.  Reduction in cellular and vascular rejection by blocking leukocyte adhesion molecule receptors. , 1993, The American journal of pathology.

[5]  N. Brousse,et al.  IMPLICATIONS OF DE NOVO ELAM‐1 AND VCAM‐1 EXPRESSION IN HUMAN CARDIAC ALLOGRAFT REJECTION , 1993, Transplantation.

[6]  P. Libby,et al.  An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[7]  A. Becker,et al.  Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. , 1992, The American journal of pathology.

[8]  M. Fishbein,et al.  Cytokine expression and endothelial cell and lymphocyte activation in human cardiac allograft rejection: an immunohistochemical study of endomyocardial biopsy samples. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  R. Ross,et al.  Vascular cell adhesion molecule-1 is induced on endothelium during acute rejection in human cardiac allografts. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  M. Yacoub,et al.  Antigenic heterogeneity of vascular endothelium. , 1992, The American journal of pathology.

[11]  M. Yacoub,et al.  INDUCTION OF VASCULAR ADHESION MOLECULES DURING REJECTION OF HUMAN CARDIAC ALLOGRAFTS , 1992, Transplantation.

[12]  M. Cybulsky,et al.  Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. , 1992, The Journal of clinical investigation.

[13]  M. Lovett,et al.  CYTOKINE GENE EXPRESSION IN REJECTING CARDIAC ALLOGRAFTS , 1992, Transplantation.

[14]  P. Libby,et al.  Immunopathology of coronary arteriosclerosis in transplanted hearts. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  A. Gown,et al.  Various cell types in human atherosclerotic lesions express ICAM-1. Further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3. , 1992, The American journal of pathology.

[16]  J. Coucher,et al.  Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. , 1992, The American journal of pathology.

[17]  M. Isobe,et al.  Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. , 1992, Science.

[18]  P. Libby,et al.  Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. , 1991, The American journal of pathology.

[19]  C. Orosz,et al.  The role of vascular endothelial cells in transplantation. , 1991, Archives of pathology & laboratory medicine.

[20]  M. Cybulsky,et al.  Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.

[21]  G. Rice,et al.  Induced expression of endothelial-leukocyte adhesion molecules in human cardiac allografts. , 1991, Transplantation.

[22]  P. Libby,et al.  Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[23]  M. Hammond,et al.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. , 1990, The Journal of heart transplantation.

[24]  R. Tizard,et al.  Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes , 1989, Cell.

[25]  P. Libby,et al.  Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis. , 1989, Transplantation proceedings.

[26]  R. Cotran,et al.  Identification of an inducible endothelial-leukocyte adhesion molecule. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M E Billingham,et al.  Cardiac transplant atherosclerosis. , 1987, Transplantation proceedings.

[28]  Michael Loran Dustin,et al.  Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). , 1986, Journal of immunology.

[29]  D. Mason,et al.  Effector mechanisms in allograft rejection. , 1986, Annual review of immunology.

[30]  A. Gown,et al.  A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes , 1985, The Journal of cell biology.

[31]  D. Wagner,et al.  Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization , 1984, The Journal of cell biology.

[32]  T. Kindt,et al.  Differentiation antigens identify subpopulations of rabbit T and B lymphocytes. Definition by flow cytometry , 1983, The Journal of experimental medicine.

[33]  J. Learmonth Surgery of the Blood-Vessels , 1916, Edinburgh medical journal.